Clinical Trial Update: N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update concerns using N-acetylcysteine to prevent contrast-induced nephropathy in critically ill patients undergoing contrast-enhanced CT. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Unity Health Toronto | Conditions: Contrast Induced Nephropathy, Critically Ill | Phase 2, Phase 3 | Status: COMPLETED